Literature DB >> 11313276

The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling.

K Izutsu1, M Kurokawa, Y Imai, K Maki, K Mitani, H Hirai.   

Abstract

Evi-1 is a zinc finger nuclear protein whose inappropriate expression leads to leukemic transformation of hematopoietic cells in mice and humans. This was previously shown to block the antiproliferative effect of transforming growth factor beta (TGF-beta). Evi-1 represses TGF-beta signaling by direct interaction with Smad3 through its first zinc finger motif. Here, it is demonstrated that Evi-1 represses Smad-induced transcription by recruiting C-terminal binding protein (CtBP) as a corepressor. Evi-1 associates with CtBP1 through one of the consensus binding motifs, and this association is required for efficient inhibition of TGF-beta signaling. A specific inhibitor for histone deacetylase (HDAc) alleviates Evi-1-mediated repression of TGF-beta signaling, suggesting that HDAc is involved in the transcriptional repression by Evi-1. This identifies a novel function of Evi-1 as a member of corepressor complexes and suggests that aberrant recruitment of corepressors is one of the mechanisms for Evi-1-induced leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313276     DOI: 10.1182/blood.v97.9.2815

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  67 in total

1.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.

Authors:  D Liu; B L Black; R Derynck
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

2.  Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer.

Authors:  Xiyun Deng; Yanna Cao; Yan Liu; Fazhi Li; Kamalanathan Sambandam; Srinivasan Rajaraman; Archibald S Perkins; Alan P Fields; Mark R Hellmich; Courtney M Townsend; E Aubrey Thompson; Tien C Ko
Journal:  Mol Carcinog       Date:  2011-12-07       Impact factor: 4.784

Review 3.  Evi-1 as a critical regulator of leukemic cells.

Authors:  Susumu Goyama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-06-08       Impact factor: 2.490

4.  Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription.

Authors:  Xia Lin; Yao-Yun Liang; Baohua Sun; Min Liang; Yujiang Shi; F Charles Brunicardi; Yang Shi; Xin-Hua Feng
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

5.  Chromatin modification of Notch targets in olfactory receptor neuron diversification.

Authors:  Keita Endo; M Rezaul Karim; Hiroaki Taniguchi; Alena Krejci; Emi Kinameri; Matthias Siebert; Kei Ito; Sarah J Bray; Adrian W Moore
Journal:  Nat Neurosci       Date:  2011-12-25       Impact factor: 24.884

6.  Hamlet Notches fate.

Authors:  Dietmar Schmucker; Bassem A Hassan
Journal:  Nat Neurosci       Date:  2012-01-26       Impact factor: 24.884

7.  Role of the C-terminal binding protein PXDLS motif binding cleft in protein interactions and transcriptional repression.

Authors:  Kate G R Quinlan; Alexis Verger; Alister Kwok; Stella H Y Lee; José Perdomo; Marco Nardini; Martino Bolognesi; Merlin Crossley
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

8.  C-terminal binding proteins (CtBPs) attenuate KLF4-mediated transcriptional activation.

Authors:  Gang Liu; Hai Zheng; Walden Ai
Journal:  FEBS Lett       Date:  2009-09-12       Impact factor: 4.124

9.  Changes in ovarian protein expression during primordial follicle formation in the hamster.

Authors:  Anindit Mukherjee; Nichole Reisdorph; Chttibabu Guda; Sanjit Pandey; Shyamal K Roy
Journal:  Mol Cell Endocrinol       Date:  2011-07-28       Impact factor: 4.102

Review 10.  Runx1/AML1 in normal and abnormal hematopoiesis.

Authors:  Tetsuya Yamagata; Kazuhiro Maki; Kinuko Mitani
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.